Venmax Drugs And Pharmaceuticals fundamental analysis
VENMAX
27.29
0.79 (2.98%)Last updated on 13 Jan, 2026 | 12:00 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Venmax Drugs And Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.86
Sector P/B
0.96
Sec. Div. Yield
0.57
Venmax Drugs And Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 69.86. Its P/B Ratio stands at 0, while the sector’s is 0.96. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Venmax Drugs And Pharmaceuticals Score Card
Price
Expensive
Growth
Poor
Quality
Poor
Management
Poor
On its scorecard, Venmax Drugs And Pharmaceuticals reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
